封面
市場調查報告書
商品編碼
1542931

全球遠端監控穿戴式裝置市場 - 2024-2031

Global Remote Monitoring Wearables Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年,全球遠端監控穿戴式裝置市場規模達54億美元,預計到2031年將達到151億美元,2024-2031年預測期間複合年成長率為14.1%。

遠端監控穿戴式裝置功能是一種技術小工具,旨在收集用戶提供的健康資料並將其發送給個人健康應用程式或醫療保健從業者。這些小工具可以連續追蹤眾多生理參數,幫助使用者採取健康預防措施。

穿戴式裝置可以透過藍牙或 Wi-Fi 連接到智慧型手機或雲,與醫療保健從業者或健康應用程式共享即時資料。用於遠端患者監測的穿戴式設備可以輕鬆地與遠距醫療平台整合,使醫療專業人員能夠遠端觀察患者並即時修改治療方案。

市場動態:

驅動程式和限制

慢性病盛行率增加

慢性病盛行率的上升預計將推動市場成長。為了正確管理症狀,糖尿病、高血壓和心血管問題等慢性疾病需要持續的健康監測。具有遠端監控功能的穿戴式設備使患者能夠即時追蹤他們的健康狀況和生命徵象,從而改善對他們病情的管理。

慢性病的盛行率正在增加,預計這將增加醫療保健提供者管理患者健康狀況和症狀的能力。

例如,2023 年 6 月,華盛頓大學健康指標與評估研究所表示,全球有超過 5 億人患有糖尿病,影響每個國家各個年齡層的男性、女性和兒童,而這個數字預計未來30 年人口將增加一倍以上,達到13 億。

透過讓患者和醫療專業人員能夠存取最新資料,穿戴式裝置有助於主動處理慢性病。這使得可以及早發現可能的問題,從而及時採取行動並減少入院人數。

老年人缺乏對科技的採用

許多潛在用戶,尤其是老年人,可能會面臨對科技和智慧產品不熟悉的問題。這種不適感可能會阻礙穿戴式科技的採用,從而降低其監測健康的能力。用於遠端監控的穿戴式設備可能會導致用戶懷疑其功效和精確度。如果使用者沒有看到這些設備對他們的健康結果有明顯的好處或改善,他們可能會猶豫是否要採用這些設備。

細分市場分析

全球遠端監控穿戴式裝置市場根據裝置類型、疾病、功能、最終用戶和地區進行細分。

智慧手錶和健身追蹤器領域預計將主導市場佔有率

智慧手錶和健身追蹤器領域預計將在市場佔有率中佔據主要地位。近年來,健身追蹤器和智慧手錶不斷擴展。這些優雅的腕戴式小工具具有多種功能和感應器,可讓使用者專注於各種健康指標。

為了監測心率、睡眠模式、壓力水平和日常身體活動,醫生經常推薦智慧手錶和健身追蹤器。此外,其中一些設備具有心電圖監測等功能,可用於識別可能的心臟問題和心律異常。

技術的不斷進步以及患者和醫療保健提供者使用舒適的公司越來越多的先進設備預計將推動該細分市場的成長。

例如,2024 年7 月,物聯網(IoT) 公司KORE 宣布推出一款用於虛擬病患監護的智慧手錶,名為mCareWatch 241。追蹤、提醒、心率監測器、快速撥號、跌倒偵測、計步器、地理圍欄警報、非運動偵測以及行動應用程式和網路儀表板。

此外,2024 年 7 月 12 日,三星推出了其擴展的穿戴式產品系列,包括備受關注的新款 Galaxy Ring,它可以與智慧型手機和智慧手錶進行端到端整合,24/7 全天候佩戴。這款輕巧的設備擁有一套感測器,可連續監測關鍵的健康指標,包括睡眠模式、心率變異性和全天 24 小時的活動水平。

市場地理分析

預計北美將在遠端監控穿戴式裝置市場佔有率中佔據重要地位

北美在市場佔有率中佔有重要地位。技術進步不斷進步,慢性病盛行率不斷上升,個人意識不斷增強。該地區大量設備製造商的存在也有望使該地區在市場佔有率上佔據主導地位。

例如,2023 年 6 月,STAT Health 推出了一款 24/7 入耳式穿戴式一般健康產品,可測量頭部的血流量,以便更好地了解站立時發生的身體狀況。

此外,2022 年 11 月,遠距復健遠端患者監測穿戴式解決方案開發商 Sensoria Health 推出了第一個真正的穿戴式遠距復健平台。 Sensoria 提供以患者為中心的多設備行動和雲端軟體遠端復健系統,使物理治療師和臨床醫生能夠輕鬆有效地遠端監控患者群體中最常見的狀況。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 慢性病盛行率增加
    • 限制
      • 老年人缺乏對科技的採用
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 報銷分析
  • 專利分析
  • SWOT分析
  • DMI 意見

第 6 章:按裝置類型

  • 智慧手錶和健身追蹤器
  • 連續血糖監測儀 (CGM)
  • 穿戴式心電圖監視器
  • 遠端監控補丁
  • 其他

第 7 章:依疾病分類

  • 心血管疾病
  • 氣喘
  • 阿茲海默症
  • 腎臟疾病
  • 其他

第 8 章:按功能

  • 心率追蹤
  • ECG(心電圖)
  • 血氧濃度 (SpO2) 監測
  • 睡眠品質監測
  • 身體活動監測
  • 其他

第 9 章:最終用戶

  • 醫院
  • 診所
  • 其他

第 10 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章:公司簡介

  • MedIoTek Health Systems
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • BioIntelliSense, Inc.
  • Apple Inc.
  • AliveCor India
  • Koninklijke Philips NV,
  • Garmin Ltd.
  • Samsung Health
  • Biobeat
  • Qardio, Inc.
  • Fitbit (*LIST NOT EXHAUSTIVE)

第 13 章:附錄

簡介目錄
Product Code: MD8602

Report Overview

Global Remote Monitoring Wearables Market reached US$ 5.4 billion in 2023 and is expected to reach US$ 15.1 billion by 2031, growing at a CAGR of 14.1% during the forecast period 2024-2031.

Remote monitoring wearables capabilities are technological gadgets designed to gather and send user-provided health data to personal health applications or healthcare practitioners. These gadgets provide the continuous tracking of numerous physiological parameters, assisting users in taking preventative measures for their health.

Wearables can share real-time data with healthcare practitioners or health apps by connecting to smartphones or the cloud via Bluetooth or Wi-Fi. Wearables for remote patient monitoring can easily be integrated with telehealth platforms, giving medical professionals the ability to watch patients from a distance and modify treatment regimens in real-time.

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases is expected to drive the market growth. To properly manage symptoms, chronic disorders like diabetes, hypertension, and cardiovascular issues require continual health monitoring. Wearables with remote monitoring allow patients to track their health measures and vital signs in real time, improving the management of their conditions.

The prevalence of chronic diseases is increasing, this is expected to increase healthcare providers to manage their patient's health conditions and manage their symptoms.

For instance, in June 2023, the Institute for Health Metrics and Evaluation of the University of Washington stated that more than half a billion people are living with diabetes worldwide, affecting men, women, and children of all ages in every country, and that number is projected to more than double to 1.3 billion people in the next 30 years.

By giving patients and medical professionals access to up-to-date data, wearables facilitate the proactive handling of chronic diseases. This makes it possible to detect possible problems at an early stage, allowing timely action and lowering the number of hospital admissions.

Lack of adoption of technology by elderly people

The lack of familiarity with technology and smart gadgets may be faced by many potential users, elderly people in particular. Wearable technology adoption can be hampered by this discomfort, which would reduce its ability to monitor health. Wearables for remote monitoring can lead users to doubt their efficacy and precision. Users may be hesitant to adopt these gadgets if they don't see an obvious benefit or improvement in their health results.

Market Segment Analysis

The global remote monitoring wearables market is segmented based on device type, disease, function, end-user, and region.

The smartwatches and fitness trackers segment is expected to dominate the market share

The smartwatches and fitness trackers segment is expected to hold a major position in the market share. In recent years, fitness trackers and smartwatches have expanded. These elegant, wrist-worn gadgets are featured with functions and sensors that let users keep an eye on a variety of health indicators.

For monitoring heart rate, sleep patterns, stress levels, and everyday physical activity, doctors frequently recommend smartwatches and fitness trackers. Additionally, some of these devices have abilities like ECG monitoring, which can be used to identify possible cardiac problems and abnormal heart rhythms.

The rising advancements in technology and an increasing number of advanced devices by the companies that are comfortable to use by the patients and healthcare providers are expected to drive the segment growth.

For instance, in July 2024, KORE, an Internet of Things (IoT) company announced the launch of a smartwatch for virtual patient monitoring called mCareWatch 241. The watch features an SOS setting that enables wearers to obtain emergency assistance, call capabilities, GPS tracking, reminders, a heart rate monitor, speed dialing, fall detection, a pedometer, a geo-fence alarm, non-movement detection, and a mobile app and web dashboard.

Additionally, on July 12, 2024, Samsung unveiled its expanded slate of wearable products, including the highly-buzzed new Galaxy Ring that can be worn 24/7 with end-to-end integration with its smartphones and smartwatches. The lightweight device boasts a suite of sensors that continuously monitor key health metrics including sleep patterns, heart rate variability, and activity levels 24 hours a day.

Market Geographical Analysis

North America is expected to hold a significant position in the remote monitoring wearables market share

North America holds a significant position in the market share. The rising technological advancements, increasing prevalence of chronic diseases, and increasing awareness among individuals. The presence of a large number of device manufacturers in the region is also expected to hold the region in a dominant position in the market share.

For instance, in June 2023, STAT Health introduced a 24/7 in-ear wearable general wellness product that measures blood flow to the head to allow a better understanding of conditions in the body that occur upon standing.

Additionally, in November 2022, Sensoria Health, a developer of tele-rehab remote patient monitoring wearable solutions, introduced the first truly wearable telerehabilitation platform. Sensoria offers a patient-centric, multi-device mobile and cloud software tele-rehab system that makes it easy and efficient for physical therapists and clinicians to remotely monitor the most common conditions in their patient population.

Market Segmentation

By Device Type

  • Smartwatches and Fitness Trackers
  • Continuous Glucose Monitors (CGMs)
  • Wearable ECG Monitors
  • Remote Monitoring Patches
  • Others

By Disease

  • Cardiovascular Diseases
  • Asthma
  • Alzheimer Disease
  • Kidney Diseases
  • Others

By Function

  • Heart Rate Tracking
  • ECG (Electrocardiogram)
  • Blood Oxygen Levels (SpO2) Monitoring
  • Sleep Quality Monitoring
  • Physical Activity Monitoring
  • Others

By End-User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Market Competitive Landscape

The major global players in the market include MedIoTek Health Systems, BioIntelliSense, Inc., Apple Inc., AliveCor India, Koninklijke Philips N.V., Garmin Ltd., Samsung Health, Biobeat, Qardio, Inc., and Fitbit among others.

Why Purchase the Report?

  • To visualize the global remote monitoring wearables market segmentation based on device type, disease, function, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of remote monitoring wearables market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global remote monitoring wearables market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Disease
  • 3.3. Snippet by Function
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of chronic diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of adoption of technology by elderly people
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Device Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 6.1.2. Market Attractiveness Index, By Device Type
  • 6.2. Smartwatches and Fitness Trackers *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Continuous Glucose Monitors (CGMs)
  • 6.4. Wearable ECG Monitors
  • 6.5. Remote Monitoring Patches
  • 6.6. Others

7. By Disease

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
    • 7.1.2. Market Attractiveness Index, By Disease
  • 7.2. Cardiovascular Diseases*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Asthma
  • 7.4. Alzheimer Disease
  • 7.5. Kidney Diseases
  • 7.6. Others

8. By Function

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 8.1.2. Market Attractiveness Index, By Function
  • 8.2. Heart Rate Tracking *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. ECG (Electrocardiogram)
  • 8.4. Blood Oxygen Levels (SpO2) Monitoring
  • 8.5. Sleep Quality Monitoring
  • 8.6. Physical Activity Monitoring
  • 8.7. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
      • 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
      • 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.3.1. The U.S.
      • 10.2.3.2. Canada
      • 10.2.3.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
      • 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.4.1. Germany
      • 10.3.4.2. UK
      • 10.3.4.3. France
      • 10.3.4.4. Italy
      • 10.3.4.5. Spain
      • 10.3.4.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
      • 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.4.1. Brazil
      • 10.4.4.2. Argentina
      • 10.4.4.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
      • 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.4.1. China
      • 10.5.4.2. India
      • 10.5.4.3. Japan
      • 10.5.4.4. South Korea
      • 10.5.4.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
      • 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
      • 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease
      • 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
  • 10.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. MedIoTek Health Systems*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. BioIntelliSense, Inc.
  • 12.3. Apple Inc.
  • 12.4. AliveCor India
  • 12.5. Koninklijke Philips N.V.,
  • 12.6. Garmin Ltd.
  • 12.7. Samsung Health
  • 12.8. Biobeat
  • 12.9. Qardio, Inc.
  • 12.10. Fitbit (*LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us